Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Market Place
ABOUT THIS PAGE
A Silicic Acid (H6Si2O7), Aluminum Salt (1:2) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Silicic Acid (H6Si2O7), Aluminum Salt (1:2), including repackagers and relabelers. The FDA regulates Silicic Acid (H6Si2O7), Aluminum Salt (1:2) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Silicic Acid (H6Si2O7), Aluminum Salt (1:2) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Silicic Acid (H6Si2O7), Aluminum Salt (1:2) supplier is an individual or a company that provides Silicic Acid (H6Si2O7), Aluminum Salt (1:2) active pharmaceutical ingredient (API) or Silicic Acid (H6Si2O7), Aluminum Salt (1:2) finished formulations upon request. The Silicic Acid (H6Si2O7), Aluminum Salt (1:2) suppliers may include Silicic Acid (H6Si2O7), Aluminum Salt (1:2) API manufacturers, exporters, distributors and traders.
click here to find a list of Silicic Acid (H6Si2O7), Aluminum Salt (1:2) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Silicic Acid (H6Si2O7), Aluminum Salt (1:2) Drug Master File in Japan (Silicic Acid (H6Si2O7), Aluminum Salt (1:2) JDMF) empowers Silicic Acid (H6Si2O7), Aluminum Salt (1:2) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Silicic Acid (H6Si2O7), Aluminum Salt (1:2) JDMF during the approval evaluation for pharmaceutical products. At the time of Silicic Acid (H6Si2O7), Aluminum Salt (1:2) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Silicic Acid (H6Si2O7), Aluminum Salt (1:2) suppliers with JDMF on PharmaCompass.
Silicic Acid (H6Si2O7), Aluminum Salt (1:2) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Silicic Acid (H6Si2O7), Aluminum Salt (1:2) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Silicic Acid (H6Si2O7), Aluminum Salt (1:2) GMP manufacturer or Silicic Acid (H6Si2O7), Aluminum Salt (1:2) GMP API supplier for your needs.
A Silicic Acid (H6Si2O7), Aluminum Salt (1:2) CoA (Certificate of Analysis) is a formal document that attests to Silicic Acid (H6Si2O7), Aluminum Salt (1:2)'s compliance with Silicic Acid (H6Si2O7), Aluminum Salt (1:2) specifications and serves as a tool for batch-level quality control.
Silicic Acid (H6Si2O7), Aluminum Salt (1:2) CoA mostly includes findings from lab analyses of a specific batch. For each Silicic Acid (H6Si2O7), Aluminum Salt (1:2) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Silicic Acid (H6Si2O7), Aluminum Salt (1:2) may be tested according to a variety of international standards, such as European Pharmacopoeia (Silicic Acid (H6Si2O7), Aluminum Salt (1:2) EP), Silicic Acid (H6Si2O7), Aluminum Salt (1:2) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Silicic Acid (H6Si2O7), Aluminum Salt (1:2) USP).
LOOKING FOR A SUPPLIER?
